A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama-Birmingham
Birmingham, Alabama, United States
- Mddesert Comprehensive Breast Center
Palm Springs, California, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Cleveland Clinical Foundation
Cleveland, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Us Oncology
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2003
- Primary completion
- —
- Completion
- 31 Dec 2005
- Last update posted
- 17 Sept 2008
- Registered enrollment
- 100
- Registry id
- NCT00328432
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.